BECN1 and breast cancer: Moreover, Ueno et al. showed that beclin 1 and LC3 autophagy marker expression was higher in BC cells upon exemestane treatment, whereas in pretreatment status, the expression of stromal beclin 1 was correlated with enhanced BC cell proliferation and inadequate clinical responses to neoadjuvant endocrine therapy [248].